The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release

AUTOR(ES)

Nagai, Taku

FONTE

National Academy of Sciences

RESUMO

Tissue plasminogen activator (tPA) is a serine protease that catalyzes the conversion of plasminogen (plg) to plasmin, which in turn functions to degrade extracellular matrix proteins in the central nervous system. The tPA-plasmin system plays a role in synaptic plasticity and remodeling. Here we show that this protease system participates in the rewarding effects of morphine by acutely regulating morphine-induced dopamine release in the nucleus accumbens (NAcc). A single morphine treatment induced tPA mRNA and protein expression in a naloxone-sensitive manner, which was associated with an increase in the enzyme activity in the NAcc. The acute effect of morphine in inducing tPA expression was diminished after repeated administration. Morphine-induced conditioned place preference and hyperlocomotion were significantly reduced in tPA-/- and plg-/- mice, being accompanied by a loss of morphine-induced dopamine release in the NAcc. The defect of morphine-induced dopamine release and hyperlocomotion in tPA-/- mice was reversed by microinjections of either exogenous tPA or plasmin into the NAcc. Our findings demonstrate a previously undescribed function of the tPA-plasmin system in regulating dopamine release, which is involved in the rewarding effects of morphine.

Documentos Relacionados

• The plasminogen activator/plasmin system.
• Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.
• Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
• Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.
• Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.